Chromatin plasticity contributes to neuronal selection during memory allocation

Intramyocardial Sprouting Tip Cells Specify Coronary Arterialization

Single Cell Sequencing Analysis of Infiltrating Immune Cells in Orthotopically Implanted Liver Cancer in Mice Treated with Isotype or Anti-PD-1 Therapy

Loss of Elp3 impairs the immune response to helminths by blocking intestinal tuft cell differentiation

iSuRe-HadCre is an essential tool for effective conditional genetics

Gene expression profile of all CD4 T cells from the mesenteric lymph nodes of SPF and Nippostrongylus Brasiliensis infected mice

Single cell RNA-sequencing of esophageal epithelium from wild type and p63-KO mice

Long-lived central memory gamma delta T cells confer protection against murine cytomegalovirus reinfection

Microglia response upon demyelinating injury [snRNA-seq]

Single nuclei RNAseq of the bone fracture callus of Prss56-Nf1 KO mice

The E3 ubiquitin ligase function of the epigenetic reader PHF16 is crucial for injury-induced intestinal regeneration

Targeting oncogene-dependent TIM-3 induces T cell reprogramming thereby enhancing graft-versus-leukemia immunity - scRNAseq

MALDI imaging and LC-MS/MS-based fast, high-resolution spatial proteomics demonstrate cellular heterogeneity in situ

Effect of PTEN treatment on the subcutaneous tumor formation model of PTEN knockout B16F10 cells in C57BL/6J mice

Single-cell atlas of dura cells from non-tumor or leptomeningeal metastasis mice

TLR9 activation in large wound induces tissue repair and hair follicle regeneration via γδT cells

Single-cell RNA sequencing reveals a role of Phf2 in promoting the exit of postnatal neural stem cell from shallow quiescence.

STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia [scRNA-seq]

STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia.

Gene expression profile at single cell level of non-parenchymal cells from Fibrosis and Tumor (FAT) Metabolic Dysfunction-Associated Steatohepatitis (MASH) model vs healthy liver at 12- and 24-week timepoints.